Sepsis, Severe Clinical Trial
— IPSEPSISOfficial title:
Immune Profile of Patients With Positive Blood Cultures and Multiple Organ Dysfunctions
The immune response can acquire different profiles (proinflammatory and anti-inflammatory response) depending on the activating agent.The objective of this study is to compare the immunological profile in patients with severe sepsis and positive blood cultures.
Status | Not yet recruiting |
Enrollment | 40 |
Est. completion date | July 1, 2020 |
Est. primary completion date | July 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: severe sepsis - Exclusion Criteria: VIH immunosuppression Autoimmune disease Neoplasm Pregnant women Cirrhosis Bone Marrow Disease Malnutrition. - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hospital El Cruce |
Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005 Jan 1-7;365(9453):63-78. Review. — View Citation
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. — View Citation
Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, Hoshi S, Yoshida M. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock. 1992 Dec;38(4):264-74. — View Citation
Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013 Jan-Feb;50(1):23-36. doi: 10.3109/10408363.2013.764490. Review. — View Citation
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016 May 23;353:i1585. doi: 10.1136/bmj.i1585. Review. — View Citation
Guenter CA, Hinshaw LB. Comparison of septic shock due to gram-negative and gram-positive organisms. Proc Soc Exp Biol Med. 1970 Jul;134(3):780-3. — View Citation
Janols H, Bergenfelz C, Allaoui R, Larsson AM, Rydén L, Björnsson S, Janciauskiene S, Wullt M, Bredberg A, Leandersson K. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol. 2014 No — View Citation
Minasyan H. Sepsis and septic shock: Pathogenesis and treatment perspectives. J Crit Care. 2017 Aug;40:229-242. doi: 10.1016/j.jcrc.2017.04.015. Epub 2017 Apr 18. Review. — View Citation
Zeni F, Vindimian M, Pain P, Gery P, Tardy B, Bertrand JC. Antiinflammatory and proinflammatory cytokines in patients with severe sepsis. J Infect Dis. 1995 Oct;172(4):1171-2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of the proinflammatory response. | Plasma level comparison of: TNF-alpha, IL-6 and IL-1 between both groups, by flow cytometry. | Six months | |
Primary | Comparison of the anti-inflammatory response | Plasma level comparison of: TNF-alpha receptor, INF-gamma and IL-10 between both groups, by flow cytometry. | Six months | |
Secondary | Mortality comparison | Mortality between both groups will be compared for the 28th day of admission to the protocol. | Six months | |
Secondary | SOFA score comparison | Multiple organ dysfunction will be measured with the SOFA score at the time of admission to the protocol and between days 3 to 5. The severity score will be compared between groups. | Six months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Recruiting |
NCT04796636 -
High-dose Intravenous Vitamin C in Patients With Septic Shock
|
Phase 1 | |
Terminated |
NCT04134624 -
EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
|
N/A | |
Withdrawn |
NCT04821414 -
Effects of IL-1β and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children
|
||
Recruiting |
NCT05357339 -
Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock
|
N/A | |
Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
Completed |
NCT04833621 -
Is NMES Treatment in Sepsis/ Septic Shock Patients Protective in Development of ICU-AW?
|
N/A | |
Not yet recruiting |
NCT04105400 -
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
|
||
Completed |
NCT04459572 -
As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR
|
N/A | |
Completed |
NCT04508296 -
The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality
|
N/A | |
Recruiting |
NCT03685214 -
Comparison of Balanced Crystalloids and Normal Saline in Septic Patients
|
N/A | |
Not yet recruiting |
NCT04850456 -
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
|
||
Completed |
NCT04747795 -
Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments
|
Phase 3 | |
Terminated |
NCT03821038 -
Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
|
Phase 2 | |
Completed |
NCT05246969 -
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
|
||
Recruiting |
NCT05442710 -
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
|
Phase 2 | |
Completed |
NCT05467605 -
Effect of Probiotics on Cytokines in Sepsis in Children
|
N/A | |
Completed |
NCT03974386 -
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock
|
N/A | |
Recruiting |
NCT04203979 -
Sepsis: From Syndrome to Personalized Care
|
||
Not yet recruiting |
NCT03367026 -
Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine
|
N/A |